Clinical Trial Update: Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fixed-dose brinzolamide 1%/brimonidine 0.2% versus the individual components brinzolamide 1% and brimonidine 0.2% for efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Brimonidine 0.2% (brimonidine)
• Brinzolamide 1% (brinzolamide)
• Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-05-13